Why a Connecticut pharma firm moved its C-suite to Blue Bell

A Connecticut biopharmaceutical company, with growth in its plans, has moved its executive offices and clinical operations to suburban Philadelphia. Achillion Pharmaceuticals of New Haven, Conn., has opened a 12,000-square-foot office in Blue Bell where the company has 30 employees and expects to add more. The 21-year-old company will continue to maintain a "significant" research presence in New Haven, where it also has about 30 employees. J oe Truitt, Achillion's president and CEO, said the move…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news